Ceramic/polymer nanocomposites with tunable drug delivery capability at specific disease sites
Source abstract
Abstract
Abstract Pharmaceutical agents are often used to stimulate new bone formation for the treatment of bone injuries or diseases (such as osteoporosis). However, there are several problems associated with current orthopedic drug delivery methods. First, conventional systemic administration of pharmaceutical agents may not effectively reach targeted sites and, thus, they can cause nonspecific bone formation in areas not affected by injury or disease. Second, even if intentionally delivered or implanted locally to the damaged bone tissue, these agents tend to rapidly diffuse into adjacent tissues due to weak physical bonding to their drug carriers, which limits their potential to promote prolonged bone formation in targeted areas of bone disease. Therefore, in this study, biodegradable ceramic/polymer nanocomposites were explored as novel drug carriers for orthopedic applications to prolong local drug release and, thus, improve drug effectiveness at bone disease sites. Specifically, a bone morphogenetic protein (BMP‐7) derived peptide (DIF‐7c) was used as a model drug in this study and was first loaded onto nanocrystalline hydroxyapatite (nano‐HA) by either covalent chemical attachment or physical adsorption. These drug‐carrying nano‐HA particles were then dispersed into a degradable polymer (poly‐lactide‐co‐glycolide or PLGA) matrix to create an implantable system capable of long‐term drug release. The aminophase silane covalent chemical immobilization process was utilized in this study. These nanocomposite‐based drug delivery systems were then characterized for drug loading efficiency andin vitrodrug release. Results demonstrated that DIF‐7c was successfully immobilized onto nano‐HA placed in PLGA. Moreover, a greater prolonged two‐phase release profile (of more than 3 months) was achieved when using aminophase silane chemical immobilization to nano‐HA particles. Since previous studies have demonstrated greaterin vivobone growth on nano‐ compared with micron‐HA particles placed in rat calvaria, this study continued to demonstrate that ceramic/polymer nanocomposites are promising candidates as novel orthopedic materials to promote bone regeneration. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. U.S. Department of Health and Human Services · 2004
2. 10.1089/ten.2006.12.178710.1089/ten.2006.12.1787 ↗
3. 10.1016/S0140-6736(04)16727-510.1016/S0140-6736(04)16727-5 ↗
4. 10.1016/j.biomaterials.2007.09.04010.1016/j.biomaterials.2007.09.040 ↗
5. 10.1023/A:101584210877210.1023/A:1015842108772 ↗
6. 10.1208/pt03010110.1208/pt030101 ↗
7. 10.1002/jbm.a.3115110.1002/jbm.a.31151 ↗
8. 10.1016/j.biomaterials.2003.07.00310.1016/j.biomaterials.2003.07.003 ↗
9. 10.1002/jbm.a.3073410.1002/jbm.a.30734 ↗
10. 10.1002/jbm.a.3092310.1002/jbm.a.30923 ↗
11. LiuH.Design fabrication and evaluation of 2D to 3D nanostructured ceramic/polymer composites for orthopedic regeneration and controlled drug delivery Ph.D. Dissertation. Providence RI: Brown University;2008.
12. 10.1016/S0142-9612(00)00075-210.1016/S0142-9612(00)00075-2 ↗
13. 10.1002/jbm.a.1051910.1002/jbm.a.10519 ↗
14. 10.1016/j.biomaterials.2006.08.04910.1016/j.biomaterials.2006.08.049 ↗
15. 10.2217/17435889.1.2.16910.2217/17435889.1.2.169 ↗
16. 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B ↗
17. 10.1016/S0142-9612(00)00322-710.1016/S0142-9612(00)00322-7 ↗
18. 10.1126/science.320124110.1126/science.3201241 ↗
19. 10.1073/pnas.87.6.222010.1073/pnas.87.6.2220 ↗
20. 10.1083/jcb.113.3.68110.1083/jcb.113.3.681 ↗
21. 10.2106/00004623-199274050-0000510.2106/00004623-199274050-00005 ↗
22. 10.1097/00006534-199101000-0001410.1097/00006534-199101000-00014 ↗
23. 10.1001/archotol.1991.0187022004900910.1001/archotol.1991.01870220049009 ↗
24. Healing of segmental femoral defects in sheep using recombinant human bone morphogenetic protein
25. 10.1002/jbm.a.3029910.1002/jbm.a.30299 ↗
26. 10.1002/jbm.a.3052310.1002/jbm.a.30523 ↗
27. 10.1016/j.biomaterials.2004.02.01010.1016/j.biomaterials.2004.02.010 ↗
28. 10.1097/00003086-199810001-0001810.1097/00003086-199810001-00018 ↗
29. 10.1097/00007632-200104150-0001710.1097/00007632-200104150-00017 ↗
30. 10.1016/j.biomaterials.2003.11.02810.1016/j.biomaterials.2003.11.028 ↗
31. 10.1007/s00264-007-0424-810.1007/s00264-007-0424-8 ↗
32. 10.1007/s00264-007-0422-x10.1007/s00264-007-0422-x ↗
33. 10.1007/s00264-007-0423-910.1007/s00264-007-0423-9 ↗
34. 10.1111/j.1445-2197.2007.04175.x10.1111/j.1445-2197.2007.04175.x ↗
35. 10.1007/s00264010026210.1007/s002640100262 ↗
36. 10.1002/jbm.a.3224610.1002/jbm.a.32246 ↗
37. 10.1016/j.biomaterials.2005.10.04110.1016/j.biomaterials.2005.10.041 ↗
38. Stoichiometric apatite fine single crystals by hydrothermal synthesis
39. Hydrothermal synthesis and characterization of fine apatite crystals10.4028/www.scientific.net/MSF.34-36.371 ↗
40. 10.1021/la00013a02310.1021/la00013a023 ↗
41. 10.1016/j.biomaterials.2005.12.00810.1016/j.biomaterials.2005.12.008 ↗
42. 10.1021/ac00005a00510.1021/ac00005a005 ↗
43. Instructions for Micro BCA™ Protein Assay Kit. Pierce. Also available athttp://www.piercenet.com/files/0412dh5.pdf.
44. 10.2147/nano.2006.1.4.54110.2147/nano.2006.1.4.541 ↗
45. Degradation behavior of porous poly (α‐hydroxy acid)/hydroxyapatite composite scaffolds
46. 10.1007/BF0321835510.1007/BF03218355 ↗
47. 10.1016/j.jconrel.2005.05.02510.1016/j.jconrel.2005.05.025 ↗
48. GeninFY LuoP DashAK. Hydroxyapatite Based Drug Delivery Implant for Cancer Treatment. U.S. Pat. 6 767 550 2004.
49. 10.1016/j.ejpb.2007.02.01810.1016/j.ejpb.2007.02.018 ↗
50. 10.1002/jbm.a.3115110.1002/jbm.a.31151 ↗